Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 10 | 2023 | 261 | 3.270 |
Why?
|
| Xanthogranuloma, Juvenile | 2 | 2022 | 38 | 1.000 |
Why?
|
| Histiocytosis, Sinus | 1 | 2022 | 86 | 0.810 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 184 | 0.740 |
Why?
|
| Histiocytosis | 1 | 2020 | 54 | 0.720 |
Why?
|
| Pneumothorax | 1 | 2020 | 153 | 0.670 |
Why?
|
| Telomere Shortening | 1 | 2019 | 56 | 0.660 |
Why?
|
| Benzimidazoles | 1 | 2022 | 428 | 0.660 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2016 | 52 | 0.550 |
Why?
|
| Telomerase | 1 | 2019 | 525 | 0.540 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 393 | 0.520 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 1283 | 0.500 |
Why?
|
| Neutropenia | 1 | 2019 | 968 | 0.500 |
Why?
|
| Lung Diseases | 1 | 2020 | 717 | 0.490 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 500 | 0.480 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 310 | 0.470 |
Why?
|
| Rituximab | 1 | 2018 | 1528 | 0.460 |
Why?
|
| Hodgkin Disease | 2 | 2019 | 1429 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 639 | 0.390 |
Why?
|
| Glioma | 1 | 2022 | 1963 | 0.380 |
Why?
|
| Mutation | 4 | 2019 | 15179 | 0.370 |
Why?
|
| Histiocytes | 2 | 2022 | 94 | 0.360 |
Why?
|
| Fever of Unknown Origin | 2 | 2018 | 63 | 0.330 |
Why?
|
| Infant | 10 | 2022 | 13310 | 0.290 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 4654 | 0.280 |
Why?
|
| Child, Preschool | 10 | 2022 | 16273 | 0.270 |
Why?
|
| Child | 14 | 2022 | 29154 | 0.270 |
Why?
|
| Adolescent | 13 | 2022 | 31252 | 0.260 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2004 | 16 | 0.250 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 755 | 0.220 |
Why?
|
| Interferon-gamma | 2 | 2022 | 1144 | 0.200 |
Why?
|
| Meningioma | 1 | 2004 | 289 | 0.200 |
Why?
|
| Pleurodesis | 1 | 2020 | 71 | 0.180 |
Why?
|
| Thiotepa | 1 | 2020 | 118 | 0.180 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 441 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 371 | 0.180 |
Why?
|
| Humans | 26 | 2023 | 261506 | 0.180 |
Why?
|
| Chest Tubes | 1 | 2020 | 101 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 709 | 0.180 |
Why?
|
| Etanercept | 1 | 2018 | 54 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2017 | 11965 | 0.170 |
Why?
|
| Blood Cells | 1 | 2019 | 127 | 0.170 |
Why?
|
| Remission Induction | 2 | 2023 | 3569 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 366 | 0.160 |
Why?
|
| Sepsis | 2 | 2021 | 652 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 2291 | 0.160 |
Why?
|
| Smad6 Protein | 1 | 2017 | 14 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 156 | 0.150 |
Why?
|
| Osteopontin | 1 | 2018 | 148 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2018 | 834 | 0.150 |
Why?
|
| Janus Kinases | 1 | 2018 | 174 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 15862 | 0.150 |
Why?
|
| Cytarabine | 1 | 2023 | 1973 | 0.140 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 588 | 0.140 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 238 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 280 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 1033 | 0.140 |
Why?
|
| Hydroxyurea | 1 | 2016 | 204 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 1375 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2019 | 745 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1331 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2359 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 264 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8223 | 0.120 |
Why?
|
| Adult | 10 | 2019 | 77950 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 4849 | 0.120 |
Why?
|
| Clonal Evolution | 1 | 2016 | 253 | 0.120 |
Why?
|
| Male | 14 | 2021 | 123000 | 0.120 |
Why?
|
| Young Adult | 4 | 2022 | 21445 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 960 | 0.120 |
Why?
|
| Genetic Testing | 2 | 2021 | 1589 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 1053 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 1586 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 560 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1538 | 0.110 |
Why?
|
| Female | 13 | 2021 | 141928 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 2265 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1046 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1121 | 0.100 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 2238 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2011 | 194 | 0.100 |
Why?
|
| Exome | 1 | 2016 | 1239 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 1039 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1869 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 1399 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.080 |
Why?
|
| Mycophenolic Acid | 2 | 2018 | 148 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 4757 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 502 | 0.080 |
Why?
|
| Oxygen | 1 | 2011 | 754 | 0.070 |
Why?
|
| Biopsy | 3 | 2018 | 3443 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2017 | 2967 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 7702 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 4744 | 0.070 |
Why?
|
| Anemia | 1 | 2011 | 689 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 6550 | 0.060 |
Why?
|
| Paresis | 1 | 2004 | 54 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 5159 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5539 | 0.060 |
Why?
|
| Epilepsies, Partial | 1 | 2004 | 111 | 0.060 |
Why?
|
| Clone Cells | 1 | 2004 | 555 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 11538 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 2018 | 945 | 0.050 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2018 | 2358 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 1328 | 0.050 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 29 | 0.050 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 49 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 182 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 621 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 162 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
| Histoplasma | 1 | 2018 | 32 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2019 | 148 | 0.040 |
Why?
|
| Antigens, Fungal | 1 | 2018 | 40 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 631 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 2018 | 74 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 108 | 0.040 |
Why?
|
| Liver Failure | 1 | 2019 | 140 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 269 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 1313 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 561 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 289 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 148 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 684 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 126 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 5047 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 6100 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 2019 | 256 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 827 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 966 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1084 | 0.040 |
Why?
|
| Viral Load | 1 | 2018 | 493 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2017 | 205 | 0.040 |
Why?
|
| Mexico | 1 | 2016 | 259 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2020 | 747 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 1443 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2018 | 32848 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 482 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2019 | 388 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 462 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 698 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Pyrroles | 1 | 2018 | 576 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 492 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 848 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 906 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2020 | 1085 | 0.030 |
Why?
|
| Family | 1 | 2017 | 736 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 1035 | 0.030 |
Why?
|
| Middle Aged | 2 | 2016 | 86204 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 1242 | 0.030 |
Why?
|
| Lactates | 1 | 2011 | 112 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2018 | 1230 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2011 | 200 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1360 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 172 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1471 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 477 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3719 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5637 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7222 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6295 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 583 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3518 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 6311 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 4549 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1467 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 4113 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10001 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 34495 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 17523 | 0.010 |
Why?
|
| United States | 1 | 2016 | 15433 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 12926 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 59536 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 37905 | 0.010 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 70117 | 0.010 |
Why?
|